Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 278,917 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $15.53, for a total value of $4,331,581.01. Following the transaction, the president now owns 2,303,975 shares of the company’s stock, valued at $35,780,731.75. This represents a 10.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Stock Down 3.5 %

Shares of Alignment Healthcare stock opened at $15.25 on Friday. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $16.25. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The stock’s 50-day moving average is $13.89 and its 200 day moving average is $12.14. The firm has a market cap of $2.93 billion, a price-to-earnings ratio of -19.81 and a beta of 1.49.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Stephens reiterated an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a research note on Monday, February 24th. JPMorgan Chase & Co. boosted their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday. Barclays boosted their price target on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research note on Friday, February 28th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Stifel Nicolaus upped their target price on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP boosted its holdings in Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after acquiring an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in Alignment Healthcare by 54.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock worth $97,302,000 after acquiring an additional 3,059,596 shares in the last quarter. Millennium Management LLC boosted its holdings in Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock worth $38,122,000 after acquiring an additional 2,896,311 shares in the last quarter. Point72 Asset Management L.P. bought a new position in Alignment Healthcare in the fourth quarter worth approximately $20,087,000. Finally, Broad Bay Capital Management LP bought a new position in Alignment Healthcare in the fourth quarter worth approximately $18,804,000. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.